BROOKLYN, N.Y. (Legal Newsline) – One target of an attorney who files novel class actions is hoping an October decision will help doom the case against it. GSK Consumer Healthcare Holdings, the maker of ChapStick, says a survey conducted and cited by New York lawyer Spencer Sheehan fails to prove customers were misled by its packaging. At issue in the case are adjacent claims on tubes. An advertised lasting time of eight hours is next to a claim of 15 SPF, but GSK argues this does not mean ChapStick claims to provide sun protection for eight hours. GSK on Dec. 8 notified New York federal judge Eric Komitee of an October decision by a colleague in New York’s Southern District in one of the dozens of lawsuits Sheehan has filed against products that are vanilla-flavored.